论文部分内容阅读
堪萨斯分枝杆菌引起的疾病看来有增加的趋势。最近,日本报导堪萨斯分枝杆菌由非流行状态逐渐变成流行状态。堪萨斯分枝杆菌所致肺部疾病的化疗合理疗程尚不清楚,有人推荐18～24个月,这是利福平(RFP)问世之前,根据结核病化疗情况提出的。RFP对堪萨斯分枝杆菌所致疾病是很有效的。有人报导115例接受含有RFP的方案,在4个月内痰菌阴转率达100%。本文报导40例,男33例,女7例,伴
It appears that there is an increasing trend of the disease caused by Kansas Mycobacterium. Recently, Japan reported that M. kansasia gradually became non-endemic. The rational course of chemotherapy for lung disease caused by mycobacterium Kansas is unknown. It is recommended for 18 to 24 months, which is based on the chemotherapy of tuberculosis prior to the advent of rifampicin (RFP). RFP is very effective against mycobacterium kansasii-caused diseases. It was reported 115 cases received RFP-containing programs, sputum bacterial vaginosis rate of 100% within 4 months. This article reports 40 cases, 33 males and 7 females, with